Literature DB >> 32476868

The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?

Rajive Tandon1, Robert P Baughman2, Janice Stanley1, Ali A Khan3.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) and sarcoidosis are recognized causes of pulmonary hypertension according to the World Health Organization classification scheme. This case series describes seven patients with sarcoidosis with a mean age of 61 who developed pulmonary hypertension. They were found to have CTEPH, diagnosed by either CT pulmonary angiography or a lung ventilation perfusion scan. They all underwent confirmatory right heart catheterization showing elevated mean pulmonary artery pressures (mean of 42 mmHg - normal less than 25 mmHg). Sarcoidosis has been previously shown to be associated with increased rates of venous thromboembolic disease. In these cases, patients with sarcoidosis later developed CTEPH and this may be another mechanism in which sarcoidosis can lead to pulmonary hypertension. (Sarcoidosis Vasc Diffuse Lung Dis 2017; 34: 352-355). Copyright:
© 2017.

Entities:  

Keywords:  CTEPH; sarcoidosis

Year:  2017        PMID: 32476868      PMCID: PMC7170075          DOI: 10.36141/svdld.v34i4.5852

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  16 in total

1.  Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study.

Authors:  A P Crawshaw; C J Wotton; D G R Yeates; M J Goldacre; L-P Ho
Journal:  Thorax       Date:  2010-09-13       Impact factor: 9.139

Review 2.  Chronic thromboembolic pulmonary hypertension: a distinct disease entity.

Authors:  Irene Lang
Journal:  Eur Respir Rev       Date:  2015-06

Review 3.  Risk factors for chronic thromboembolic pulmonary hypertension.

Authors:  N H Kim; I M Lang
Journal:  Eur Respir Rev       Date:  2012-03-01

4.  Splenectomy and chronic thromboembolic pulmonary hypertension.

Authors:  X Jaïs; V Ioos; C Jardim; O Sitbon; F Parent; A Hamid; E Fadel; P Dartevelle; G Simonneau; M Humbert
Journal:  Thorax       Date:  2005-08-05       Impact factor: 9.139

5.  Venous thromboembolism and preoperative steroid use: analysis of the NSQIP database to evaluate risk in surgical patients.

Authors:  Rami S Kantar; Anthony G Haddad; Hani Tamim; Faek Jamali; Ali T Taher
Journal:  Eur J Intern Med       Date:  2015-07-03       Impact factor: 4.487

6.  Antiphospholipid antibodies. A prognostic factor in sarcoidosis?

Authors:  Y Ina; K Takada; M Yamamoto; T Sato; S Ito; S Sato
Journal:  Chest       Date:  1994-04       Impact factor: 9.410

Review 7.  Pulmonary embolism and deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Henri Bounameaux
Journal:  Lancet       Date:  2012-04-10       Impact factor: 79.321

Review 8.  The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

Authors:  F A Klok; T van der Hulle; P L den Exter; M Lankeit; M V Huisman; S Konstantinides
Journal:  Blood Rev       Date:  2014-08-15       Impact factor: 8.250

Review 9.  Chronic thromboembolic pulmonary hypertension.

Authors:  Marius M Hoeper; Michael M Madani; Norifumi Nakanishi; Bernhard Meyer; Serghei Cebotari; Lewis J Rubin
Journal:  Lancet Respir Med       Date:  2014-06-02       Impact factor: 30.700

Review 10.  Sarcoidosis and Antiphospholipid Syndrome: A Systematic Review of Cases.

Authors:  Ranjan Pathak; Raju Khanal; Madan Raj Aryal; Smith Giri; Paras Karmacharya; Basanta Pathak; Upasana Acharya; Vijaya Raj Bhatt
Journal:  N Am J Med Sci       Date:  2015-09
View more
  1 in total

Review 1.  Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Authors:  Yuri Matusov; Inderjit Singh; Yen-Rei Yu; Hyung J Chun; Bradley A Maron; Victor F Tapson; Michael I Lewis; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.